Better hemodynamic stability and lower rates of post-operative shock
Patients in the CytoSorb group had lower median Vasoactive-Inotropic Scores (27.2 [14.6–47.7] vs. 41.9 [22.4–63.2], p=0.046) and
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday.
The Dow traded up 0.27% to 37,758.26 while the NASDAQ rose 0.17% to 15,124.90. The S&P 500 also rose, gaining, 0.23% to 4,792.56.
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 50 points on Thursday.
The Dow traded up 0.14% to 37,708.15 while the NASDAQ rose 0.19% to 15,127.17. The S&P 500 also rose, gaining, 0.14% to 4,788.28.
U.S. stocks traded higher this morning, with the Dow Jones index gaining over 50 points on Thursday.
Following the market opening Thursday, the Dow traded up 0.14% to 37,708.72 while the NASDAQ rose 0.15% to 15,122.12. The S&P 500 also rose, gaining, 0.18% to 4,790.25.
CytoSorbents Corporation (NASDAQ: CTSO) released an update on the initial data analysis of primary safety and effectiveness endpoints and the final independent Data and Safety Monitoring Board for the pivotal U.S.